Buyer for clinical research company in Europe

Company to buy

Size: Medium business
Sales: 10-50 million EUR
Location: Europe
Reason for acquisition: The management wants to expand their business
#CFIE PHB186

Overview of the buyer for clinical research company in Europe

The buyer company operates in the healthcare sector. They supply drug development services to the pharma industry. There are two main segments, focused mainly on clinical research outsourcing and pharmacovigilance.

Profile (strategy) of the buyer for clinical research company in Europe

The company has over 20 years of experience in clinical and drug development services, providing solutions for all stages of drug development. The company’s strategy is centered on being a key player in the drug development industry. The company has achieved a broad and encompassing reach in the sector, with clients that range from top players in the pharma industry to small and medium companies. In addition, the company has broadened its operations to pharmacovigilance and medical information services with great success.
Overall, its differential is providing a full-cycle approach with the highest possible quality: from clinical trials, through pharmacovigilance, to medical information services. Most importantly, this relieves clients of their regulatory concerns and enables them to optimize their product value and development success.
The company successfully pursues a global strategy. Its services cover over a hundred countries worldwide. This has bolstered a strong international reputation, especially for its rare disease drug development and oncological drug development services.

Subscribe as an interested seller
Contact us to get details about this buyer for clinical research company in Europe

Activities and products of a suitable target

The target company should operate in Europe. It should have yearly revenue of around 10 to 50 million euros. Above all, the target company’s activities should preferably include pharmaceutical, clinical research, development, services, CRO, drug safety, pharmacovigilance, patient recruitment, and clinical operations.

Highlights

Operations in more than 20 countries internationally, with active clinical trials in over 60 countries
Highly-qualified and passionate staff numbering around 1,500 personnel
Over 1,500 studies were completed successfully, including oncological and rare disease studies
International recognition in rare disease drug development and oncological drug development
Expertise in clinical research, CRO, pharmacovigilance, drug safety, and clinical operations

More information on this buyer for clinical research company in Europe

Please get in touch if you are interested in learning more about this buyer for clinical research company in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.